• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架内冠状动脉再狭窄血管内放射治疗后的失败模式。

Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.

机构信息

Departments of Radiation Oncology, University of Washington, Seattle, Washington, USA.

Division of Cardiology, University of Washington, Seattle, Washington, USA.

出版信息

Catheter Cardiovasc Interv. 2022 Nov;100(5):759-762. doi: 10.1002/ccd.30399. Epub 2022 Sep 13.

DOI:10.1002/ccd.30399
PMID:36098336
Abstract

INTRODUCTION

One strategy to improve the effectiveness of intravascular brachytherapy (IVBT) is to study its failures. Previous investigations described mostly discrete, focal recurrences, typically at the proximal or distal edges of the irradiated segment after plain angioplasty or bare metal stents. We reviewed failure patterns of 30 unselected drug-eluting stent (DES) patients who had follow-up angiograms for recurrence within their IVBT-treated vessel.

METHODS

Records of 53 unselected IVBT patients treated between 2016 and 2021 were reviewed. Thirty of the 53 patients had at least one subsequent percutaneous intervention (PCI) for in-stent restenosis (ISR) after IVBT. Angiographic findings of those 30 patients with ISR within their previously irradiated vessel are reported here.

RESULTS

Of the 30 patients, 21 (70%) developed recurrent ISR within the irradiated segment. Six of the 21 patients who failed within the irradiated segment also experienced ISR proximal or distal to the irradiated segment. Only 15 patients (50%) failed exclusively within the irradiated segment. In nine patients (30%), restenosis occurred proximally and/or distally to the irradiated segment, but not inside of the irradiated segment itself.

CONCLUSIONS

We have shown here that 50% of failures after coronary IVBT for DES ISR occur exclusively within the irradiated segment. An additional 20% of patients had failure within and outside of the irradiated segment. These percentages suggest that a higher radiation dose might improve the long-term patency rates, a conclusion that should be tempered by the lack of universal follow-up.

摘要

介绍

提高血管内放射治疗(IVBT)效果的一种策略是研究其失败模式。先前的研究大多描述了离散的、局部的复发,通常在单纯血管成形术或裸金属支架后照射段的近端或远端。我们回顾了 30 例未经选择的药物洗脱支架(DES)患者的失败模式,这些患者在接受 IVBT 治疗的血管内有后续血管造影随访复发。

方法

回顾了 2016 年至 2021 年间治疗的 53 例未经选择的 IVBT 患者的记录。53 例患者中有 30 例在 IVBT 后因支架内再狭窄(ISR)至少进行了一次经皮介入治疗(PCI)。这里报告了这 30 例患者中在先前照射血管内发生 ISR 的血管造影结果。

结果

在 30 例患者中,21 例(70%)在照射段内复发 ISR。21 例在照射段内失败的患者中,有 6 例也在照射段近端或远端发生 ISR。只有 15 例患者(50%)仅在照射段内失败。在 9 例患者(30%)中,再狭窄发生在照射段近端和/或远端,但不在照射段内部。

结论

我们在这里表明,DES ISR 冠状动脉 IVBT 后 50%的失败仅发生在照射段内。另外 20%的患者在照射段内和照射段外均有失败。这些百分比表明更高的辐射剂量可能会提高长期通畅率,但应考虑到缺乏普遍随访而对这一结论持保留态度。

相似文献

1
Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.支架内冠状动脉再狭窄血管内放射治疗后的失败模式。
Catheter Cardiovasc Interv. 2022 Nov;100(5):759-762. doi: 10.1002/ccd.30399. Epub 2022 Sep 13.
2
Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis.冠状动脉血管内放射治疗复发性冠状动脉药物洗脱支架内再狭窄:系统评价和荟萃分析。
Cardiovasc Revasc Med. 2021 Feb;23:28-35. doi: 10.1016/j.carrev.2020.08.035. Epub 2020 Aug 23.
3
Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.血管内放射治疗治疗反复多层药物洗脱冠状动脉支架再狭窄。
Circ Cardiovasc Interv. 2018 Oct;11(10):e006832. doi: 10.1161/CIRCINTERVENTIONS.118.006832.
4
Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.依维莫司洗脱支架用于裸金属和药物洗脱支架内再狭窄患者:RIBS IV和V试验患者水平汇总分析结果
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003479.
5
Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.西罗莫司洗脱支架与冠状动脉内导管介导的β射线治疗支架内再狭窄的比较。
Am J Cardiol. 2005 Dec 15;96(12):1656-62. doi: 10.1016/j.amjcard.2005.07.081. Epub 2005 Oct 21.
6
Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure.冠状动脉内放射治疗复发性药物洗脱支架失败。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1259-1265. doi: 10.1016/j.jcin.2016.03.018. Epub 2016 Jun 20.
7
Coronary intravascular brachytherapy for in-stent restenosis: A review of the contemporary literature.冠状动脉腔内放射治疗支架内再狭窄:对当代文献的综述。
Brachytherapy. 2022 Sep-Oct;21(5):692-702. doi: 10.1016/j.brachy.2022.05.004. Epub 2022 Jun 17.
8
Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.血管内近距离放射治疗与药物洗脱支架治疗药物洗脱支架再狭窄患者的比较。
Am J Cardiol. 2006 Nov 15;98(10):1340-4. doi: 10.1016/j.amjcard.2006.06.027. Epub 2006 Sep 26.
9
Long-term outcome of brachytherapy treatment for coronary in-stent restenosis: Ten-year follow-up.经皮冠状动脉介入治疗后冠状动脉支架内再狭窄的长期疗效:10 年随访。
Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E211-E216. doi: 10.1002/ccd.27866. Epub 2018 Oct 2.
10
A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.比较裸金属支架和药物洗脱支架的支架内再狭窄的临床表现、血管造影模式和结局。
EuroIntervention. 2010 Feb;5(7):841-6. doi: 10.4244/eijv5i7a141.